Mainz, Germany

Hans Burgschat

This inventor holds 1 USPTO granted patent. Top assignee: Ggu Gesellschaft Fur Gesundheits- Und Umweltforschung Mbh & Co.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Burgschat. Retrieved from https://idiyas.com/inventor/hans-burgschat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hans Burgschat

Introduction

Hans Burgschat is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalable drug particles. His work is essential for improving drug delivery systems and enhancing patient care.

Latest Patents

Hans Burgschat holds a patent for a "Solidified drug supply for generating inhalable drug particles." This innovation is crucial for creating more effective inhalation therapies, which can lead to better health outcomes for patients requiring respiratory treatments. He has 1 patent to his name, showcasing his commitment to advancing medical technology.

Career Highlights

Burgschat is associated with GGU Gesellschaft für Gesundheits- und Umweltforschung mbH & Co., where he applies his expertise in health and environmental research. His role in this organization allows him to collaborate with other professionals in the field, driving forward innovative solutions in healthcare.

Collaborations

Some of his notable coworkers include Joachim Pabst and Helmut Heide. Their collective efforts contribute to the advancement of research and development in the pharmaceutical industry.

Conclusion

Hans Burgschat's work exemplifies the impact of innovation in healthcare. His patent for inhalable drug particles represents a significant step forward in medical technology. Through his career, he continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…